Publications by authors named "Albrecht Reichle"

Claim this Profile
M
MEPED as salvage therapy for relapsed/refractory Hodgkin's lymphoma incorporating edited non-oncogene addiction: mTOR as a bottleneck.
Dennis Christoph Harrer, Florian Lüke, Tobias Pukrop, Lina Ghibelli, Albrecht Reichle

Front Pharmacol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols.
Martin Neumann, Thomas Beder, Lorenz Bastian, Sonja Hänzelmann, Miriam Bultmann, Albrecht Reichle

Leukemia· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose azacitidine, pioglitazone and all- retinoic acid is safe in patients aged ≥60 years with acute myeloid leukemia refractory to standard induction chemotherapy (AMLSG 26-16/AML-ViVA): results of the safety run-in phase.
Daniel Heudobler, Florian Luke, Joachim Hahn, Matthias Grube, Pavla Schlosser, Albrecht Reichle

Haematologica· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Integrating transcriptional modulation in systemic tumor therapy.
Daniel Heudobler, Florian Lüke, Lina Ghibelli, Albrecht Reichle

Front Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peroxisome proliferator-activated receptorα/γ agonist pioglitazone for rescuing relapsed or refractory neoplasias by unlocking phenotypic plasticity.
Dennis Christoph Harrer, Florian Lüke, Tobias Pukrop, Lina Ghibelli, Christopher Gerner, Albrecht Reichle

Front Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing Genetic Tumor Heterogeneity, Post-Therapy Metastatic Spread, Cancer Repopulation, and Development of Acquired Tumor Cell Resistance.
Dennis Christoph Harrer, Florian Lüke, Tobias Pukrop, Lina Ghibelli, Albrecht Reichle

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and and/or - ITD mutations: results of the SAL MIDOKIT trial.
Leo Ruhnke, Christoph Röllig, Sylvia Herold, Tim Sauer, Christian H Brandts, Albrecht Reichle

Haematologica· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
All-oral low-dose chemotherapy TEPIP is effective and well-tolerated in patients with peripheral T-cell lymphoma.
Matthias A Fante, Dennis C Harrer, Barbara Zartner, Florian Lüke, Stephanie Mayer, Albrecht Reichle

Front Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen Deprivation Freezes Hormone-Sensitive Prostate Cancer Cells in a Reversible, Genetically Unstable Quasi-Apoptotic State, Bursting into Full Apoptosis upon Poly(ADP-ribose) Polymerase Inhibition.
Andrea Pelliccia, Francesco Capradossi, Francesca Corsi, Greta Deidda Tarquini, Emanuele Bruni, Albrecht Reichle

Int J Mol Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomodulatory therapy induces durable remissions in multi-system Langerhans cell histiocytosis.
Dennis C Harrer, Marcus Jakob, Martin Vogelhuber, Florian Lüke, Kirsten Utpatel, Albrecht Reichle

Leuk Lymphoma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Anakoinosis for promoting tumor tissue editing: Novel therapeutic opportunities for establishing clinically relevant tumor control by targeting tumor plasticity.
Daniel Heudobler, Lina Ghibelli, Albrecht Reichle

Front Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Repurposing by Tumor Tissue Editing.
Florian Lüke, Dennis Christoph Harrer, Pan Pantziarka, Tobias Pukrop, Lina Ghibelli, Albrecht Reichle

Front Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
All-Oral Low-Dose Chemotherapy TEPIP is Effective and Well-Tolerated in Relapsed/Refractory Patients With Aggressive B-Cell Lymphoma.
Matthias A Fante, Mona Felsenstein, Stephanie Mayer, Michael Gerken, Monika Klinkhammer-Schalke, Albrecht Reichle

Front Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Extramedullary Acute Promyelocytic Leukemia: An Unusual Case and Mini-Review of the Literature.
Dennis Christoph Harrer, Florian Lüke, Ingo Einspieler, Karin Menhart, Dirk Hellwig, Albrecht Reichle

Front Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Proteomic Platform Enables to Test for AML Normalization .
Samuel M Meier-Menches, Benjamin Neuditschko, Lukas Janker, Marlene C Gerner, Klaus G Schmetterer, Albrecht Reichle

Front Chem· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apoptosis as Driver of Therapy-Induced Cancer Repopulation and Acquired Cell-Resistance (CRAC): A Simple In Vitro Model of Phoenix Rising in Prostate Cancer.
Francesca Corsi, Francesco Capradossi, Andrea Pelliccia, Stefania Briganti, Emanuele Bruni, Albrecht Reichle

Int J Mol Sci· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study.
Sabine Kayser, Richard F Schlenk, Delphine Lebon, Martin Carre, Katharina S Götze, Albrecht Reichle

Haematologica· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis.
Daniel Heudobler, Albrecht Reichle, Lina Ghibelli

Front Pharmacol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial.
Christoph Röllig, Hubert Serve, Richard Noppeney, Maher Hanoun, Utz Krug, Albrecht Reichle

Leukemia· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy.
Florian Lüke, Dennis C Harrer, Joachim Hahn, Matthias Grube, Tobias Pukrop, Albrecht Reichle

Front Pharmacol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin's Disease.
Florian Lüke, Dennis C Harrer, Karin Menhart, Daniel Wolff, Ernst Holler, Albrecht Reichle

Front Pharmacol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung).
Daniel Heudobler, Christian Schulz, Jürgen R Fischer, Peter Staib, Thomas Wehler, Albrecht Reichle

Front Pharmacol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case Report.
Dennis Christoph Harrer, Karin Menhart, Stephanie Mayer, Wolfgang Herr, Albrecht Reichle

Front Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Tumor Systems Biology: How to Therapeutically Redirect Dysregulated Homeostasis in Tumor Systems (i.e., Anakoinosis).
Albrecht Reichle, Daniel Heudobler, Christopher Gerner, Pan Pantziarka, Eugenio Martinelli

Front Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronavirus disease 2019 induces multi-lineage, morphologic changes in peripheral blood cells.
Florian Lüke, Evelyn Orsó, Jana Kirsten, Hendrik Poeck, Matthias Grube, Albrecht Reichle

EJHaem· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis